FN1 and cancer: Despite presenting positive labeling in cancer tissue and negative in normal tissue, as occurs with vWF, FN1 shows an increase in the plasma of patients with GC, but its expression is not direct on the surface of the cancer cells, since the protein is present in both the membranous and cytoplasmic regions.